Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00932061 · ClinicalTrials.gov registry record · NA
Developing Biomarkers for Fibromyalgia
A NA study of Fibromyalgia, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 105
- Enrollment target
- 1
- Study location
NCT00932061 is a NA study of Fibromyalgia that has completed, run by University of Michigan. The registered enrollment target is 105 participants, below the 178-participant average among 76 other Fibromyalgia trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00932061, a NA study of Fibromyalgia, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
- 1
- Study location
Study Summary
The hypothesis of this study is that biological markers are present in the body that are good indicators of chronic pain. Eligible participants will be assessed at baseline and after receiving a series of acupuncture or "sham" acupuncture (something that resembles, but is not, active acupuncture) sessions. If the subject qualifies for the investigators' research and are subsequently enrolled in this study, they will be randomly assigned (like the flip of a coin) to one of these two groups. Acupuncture, as previously shown by this group, leads to improvements in both clinical and evoked pain associated with fibromyalgia. The study involves two magnetic resonance imaging (MRI) brain scans, one at the beginning and one at the end of the study. Another optional portion of the study would involve 2 PET (positron emission tomography) scans of the subject's brain, one at the beginning and one at the end of the study; this type of scan allows us to get more specific information about the subject's brain function during an acupuncture session.
Conditions Studied
Interventions
- OTHER Sham Treatment
- OTHER Traditional Acupuncture
Study Locations (1)
Michigan
- University of Michigan, Chronic Pain and Fatigue Research Center - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2008-06 |
| Est. Completion | 2010-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00932061
The ClinicalTrials.gov registry entry for NCT00932061 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 178-participant average among 76 other Fibromyalgia trials with a reported enrollment target (41% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Fibromyalgia appearing as the primary indexed condition, and to 2 interventions - of which Sham Treatment is the first listed.
NCT00932061 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT00932061 about?
NCT00932061 is a clinical study titled "Developing Biomarkers for Fibromyalgia". The hypothesis of this study is that biological markers are present in the body that are good indicators of chronic pain. Eligible participants will be assessed at baseline and after receiving a series of acupuncture or "sham" acupuncture (something that resembles, but is not, active acupuncture) se...
What is the current status of trial NCT00932061?
This trial is currently completed. It is a NA study. The enrollment target is 105 participants. The study started on 2008-06. Estimated completion is 2010-12.
What conditions does trial NCT00932061 study?
This clinical trial studies the following conditions: Fibromyalgia.
What interventions are being tested in trial NCT00932061?
The interventions under investigation include: Sham Treatment (OTHER), Traditional Acupuncture (OTHER).
Who is sponsoring clinical trial NCT00932061?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00932061 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fibromyalgia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Auricular Neuromodulation in Veterans With Fibromyalgia
RECRUITING · NA
-
Effects of Breathing and Attention Training (BAT) on Pain Modulation
RECRUITING · NA
-
Neural Mechanisms of Light Driven Analgesia
RECRUITING · NA
-
Fibromyalgia Sleep A to ZZZ Study
RECRUITING · NA
-
Explosive Synchronization of Brain Network Activity in Chronic Pain
RECRUITING · NA
-
Brief Pain Exposure Therapy (BPET) For Nociplastic Pain
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.